Cipla launches first biosimilar for rheumatic disorders
MUMBAI (TIP): Drug maker Cipla has locally rolled out its first biosimilar, Etanercept, used to treat rheumatic disorders. Formed through a partnership alliance, the drug sold under the Etacept brandname will be manufactured by China-based […]
